Insider Transactions in Q4 2025 at Syndax Pharmaceuticals Inc (SNDX)

SNDX Quotes by TradingView

Insider Transaction List (Q4 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Dec 01 2025
Keith A. Goldan Chief Financial Officer
SELL
Bona fide gift
Direct
1,224 -1.31%
-

Track Institutional and Insider Activities on SNDX

Follow Syndax Pharmaceuticals Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

News

Receive news related to Syndax Pharmaceuticals Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNDX